Webb20 juli 2014 · All patients with advanced gastric or gastroesophageal junction cancer should be tested for HER2 status, preferably using IHC initially, and due to the unique … Webbtoga研究奠定了曲妥珠单抗成为her2阳性胃癌一线标准治疗的地位[2],但其后针对her2阳性胃癌的诸多研究均以失败告终,单克隆抗体如帕妥珠单抗,小分子酪氨酸激酶抑制剂如 …
Förklaring av HER2 positiv och HER2 negativ Bröstcancerförbundet
WebbToGA Trial Design (n = 584) R Eligibility HER2-positive, inoperable, locally advanced, recurrent or metastatic gastroesophageal or gastric adenocarcinoma FC … WebbThe HER2 status will be evaluated by immunohistochemistry and by in situ hybridization. In the TOGA study, HER2 was positive in 33.2 % of GEJ cancers and only 20.90% of gastric cancers. The indications of trastuzumab in gastric cancer as well as the associated chemotherapies and other therapies currently assessed are reported. top 2022 college quarterbacks
2024 CGOG丨何义富教授:HER2阳性胃癌未来可期,多项研究用 …
Webb20 juli 2014 · All patients with advanced gastric or gastroesophageal junction cancer should be tested for HER2 status, preferably using IHC initially, and due to the unique characteristics of gastric cancer, specific testing/scoring guidelines should be adhered to. BackgroundIn the Trastuzumab for GAstric cancer (ToGA) study, trastuzumab plus … Webb17 dec. 2011 · The details of the ToGA trial design and methods have been reported elsewhere [].Japanese patient subgroup. To evaluate the efficacy and safety of the … Webb1 jan. 2012 · Interestingly, in the ToGA cohort, patients who had tumors demonstrating HER2 gene amplification by FISH but lacking HER2 protein overexpression by IHC did not appear to benefit from the addition of trastuzumab to their chemotherapy regimen. 10 This suggests that the level of HER2 expression, irrespective of the presence of gene … pickle and peanut transparent